An efficient computational approach to characterize DSC-MRI signals arising from three-dimensional heterogeneous tissue structures

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Semmineh, Natenael B ^a   Xu, Junzhong ^a   Boxerman, Jerrold L ^b,c   Delaney, Gary W ^d   Cleary, Paul W ^d   Gore, John C ^a,e   Quarles, C Chad ^a,e,f  

^a VANDERBILT UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d CSIRO   (Australia)

^e VANDERBILT UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; WATER;

ARTICLE; BRAIN TUMOR; CANCER TISSUE; CELL SHAPE; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING; FINITE PERTURBER FINITE DIFFERENCE METHOD; KIDNEY BLOOD VESSEL; MAGNETIC FIELD; MATHEMATICAL COMPUTING; MICRO-COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; SIMULATION; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; TISSUE STRUCTURE; VALIDATION STUDY; WATER TRANSPORT;

ALGORITHMS; BLOOD VESSELS; BRAIN NEOPLASMS; CONTRAST MEDIA; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; IMAGING, THREE-DIMENSIONAL; KINETICS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS;

EID: 84897074956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084764     Document Type: Article

References (58)

1. Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14: 249-265.
2. Meier P, Zierler KL (1954) On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 6: 731-744.
3. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191: 41-51.
4. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, et al. (2000) High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 6: 2189-2200.
5. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, et al. (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11: 83-95.
6. Bruening R, Kwong KK, Vevea MJ, Hochberg FH, Cher L, et al. (1996) Echoplanar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR Am J Neuroradiol 17: 831-840.
7. Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, et al. (2000) Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 43: 845-853.
8. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, et al. (1993) Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 189: 233-238.
9. Sugahara T, Korogi Y, Kochi M, Ushio Y, Takahashi M (2001) Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 22: 1306-1315.
10. Lemasson B, Serduc R, Maisin C, Bouchet A, Coquery N, et al. (2010) Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media. Radiology 257: 342-352.
11. Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM (1997) Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 86: 22-27.
12. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, et al. (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21: 901-909.
13. Sorensen AG, Emblem KE, Polaskova P, Jennings D, Kim H, et al. (2012) Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res 72: 402-407.
14. Kamoun WS, Ley CD, Farrar CT, Duyverman AM, Lahdenranta J, et al. (2009) Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J Clin Oncol 27: 2542-2552.
15. Rosen BR, Belliveau JW, Buchbinder BR, McKinstry RC, Porkka LM, et al. (1991) Contrast agents and cerebral hemodynamics. Magn Reson Med 19: 285-292.
16. Quarles CC, Gochberg DF, Gore JC, Yankeelov TE (2009) A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation. Phys Med Biol 54: 5749-5766.
17. Sourbron S, Heilmann M, Biffar A, Walczak C, Vautier J, et al. (2009) Bolus-tracking MRI with a simultaneous T1- and T2*-measurement. Magn Reson Med 62: 672-681.
18. Sourbron S, Heilmann M, Walczak C, Vautier J, Schad LR, et al. (2013) T2*-relaxivity contrast imaging: first results. Magn Reson Med 69: 1430-1437.
19. Bjornerud A, Sorensen AG, Mouridsen K, Emblem KE (2011) T1- and T2*-dominant extravasation correction in DSC-MRI: part I-theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 31: 2041-2053.
20. Paulson ES, Schmainda KM (2008) Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 249: 601-613.
21. Frohlich AF, Ostergaard L, Kiselev VG (2005) Theory of susceptibility-induced transverse relaxation in the capillary network in the diffusion narrowing regime. Magn Reson Med 53: 564-573.
22. Kiselev VG (2001) On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med 46: 1113-1122.
23. Kiselev VG, Posse S (1999) Analytical model of susceptibility-induced MR signal dephasing: effect of diffusion in a microvascular network. Magn Reson Med 41: 499-509.
24. Kjolby BF, Ostergaard L, Kiselev VG (2006) Theoretical model of intravascular paramagnetic tracers effect on tissue relaxation. Magn Reson Med 56: 187-197.
25. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR (1994) Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 31: 601-610.
26. Boxerman JL, Bandettini PA, Kwong KK, Baker JR, Davis TL, et al. (1995a) The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn Reson Med 34: 4-10.
27. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM (1995b) MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 34: 555-566.
28. Fisel CR, Ackerman JL, Buxton RB, Garrido L, Belliveau JW, et al. (1991) MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 17: 336-347.
29. Kennan RP, Zhong J, Gore JC (1994) Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med 31: 9-21.
30. Ogawa S, Lee TM (1990) Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med 16: 9-18.
31. Yablonskiy DA, Haacke EM (1994) Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 32: 749-763.
32. Stables LA, Kennan RP, Gore JC (1998) Asymmetric spin-echo imaging of magnetically inhomogeneous systems: theory, experiment, and numerical studies. Magn Reson Med 40: 432-442.
33. Pathak AP, Ward BD, Schmainda KM (2008) A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: the finite perturber method. Neuroimage 40: 1130-1143.
34. Pathak AP, Rand SD, Schmainda KM (2003) The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose. J Magn Reson Imaging 18: 397-403.
35. Hwang SN, Chin CL, Wehrli FW, Hackney DB (2003) An image-based finite difference model for simulating restricted diffusion. Magn Reson Med 50: 373-382.
36. Xu J, Does MD, Gore JC (2007) Numerical study of water diffusion in biological tissues using an improved finite difference method. Phys Med Biol 52: N111-126.
37. Mangla R, Kolar B, Zhu T, Zhong J, Almast J, et al. (2011) Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 32: 1004-1010.
38. Delaney GW, Cleary PW (2010) The packing properties of superellipsoids. Europhys Lett 89: 34002.
39. Christen T, Zaharchuk G, Pannetier N, Serduc R, Joudiou N, et al. (2012) Quantitative MR estimates of blood oxygenation based on T2*: a numerical study of the impact of model assumptions. Magn Reson Med 67: 1458-1468.
40. Pannetier NA, Debacker CS, Mauconduit F, Christen T, Barbier EL (2013) A simulation tool for dynamic contrast enhanced MRI. PLoS One 8: e57636.
41. Rybaczuk M, Kedzia A, Paradowski L (2002) Fractal characteristics of brain vessel microangioarchitecture during the fetal period. Med Sci Monit 8: MT145-152.
42. Schreiner W, Neumann F, Neumann M, End A, Muller MR (1996) Structural quantification and bifurcation symmetry in arterial tree models generated by constrained constructive optimization. J Theor Biol 180: 161-174.
43. Murray CD (1926) The Physiological Principle of Minimum Work: I. The Vascular System and the Cost of Blood Volume. Proc Natl Acad Sci U S A 12: 207-214.
44. Simpson NE, He Z, Evelhoch JL (1999) Deuterium NMR tissue perfusion measurements using the tracer uptake approach: I. Optimization of methods. Magn Reson Med 42: 42-52.
45. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W (1999) Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT-initial experience. Radiology 210: 269-276.
46. Weisskoff RM, Kiihne S (1992) MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood. Magn Reson Med 24: 375-383.
47. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, et al. (2006) Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 41: 213-221.
48. Klassen LM, Menon RS (2007) NMR simulation analysis of statistical effects on quantifying cerebrovascular parameters. Biophys J 92: 1014-1021.
49. Hall MG, Alexander DC (2009) Convergence and parameter choice for Monte-Carlo simulations of diffusion MRI. IEEE Trans Med Imaging 28: 1354-1364.
50. Beaumont M, Lemasson B, Farion R, Segebarth C, Remy C, et al. (2009) Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J Cereb Blood Flow Metab 29: 1714-1726.
51. Marty B, Djemai B, Robic C, Port M, Robert P, et al. (2013) Hindered diffusion of MRI contrast agents in rat brain extracellular micro-environment assessed by acquisition of dynamic T1 and T2 maps. Contrast Media Mol Imaging 8: 12-19.
52. Newman GC, Hospod FE, Patlak CS, Fain SE, Pulfer KA, et al. (2006) Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2*MRI. J Cereb Blood Flow Metab 26: 760-770.
53. Gabrys E, Rybaczuk M, Kedzia A (2005) Fractal models of circulatory system. Symmetrical and asymmetrical approach comparison. Chaos Solitons & Fractals 24(3): 707-715.
54. Gabrys E, Rybaczuk M, Kedzia A (2006) Blood flow simulation through fractal models of circulatory system. Chaos Solitons & Fractals 27(1): 1-7.
55. Karshafian R, Burns PN, Henkelman MR (2003) Transit time kinetics in ordered and disordered vascular trees. Phys Med Biol 48: 3225-3237.
56. Boxerman JL, Paulson ES, Prah MA, Schmainda KM (2013) The Effect of Pulse Sequence Parameters and Contrast Agent Dose on Percentage Signal Recovery in DSC-MRI: Implications for Clinical Applications. AJNR Am J Neuroradiol.
57. Marques JP, Bowtell R (2005) Application of a fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts in Magnetic Resonance Part B-Magnetic Resonance Engineering 25B(1): 65-78.
58. Salomir R, Senneville BDD, Moonen CTW (2003) A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility. Concepts in Magnetic Resonance Part B-Magnetic Resonance Engineering 19B(1): 26-34.